Use of pre-ART laboratory screening to identify renal, hepatic and haematological abnormalities in Côte d'Ivoire

P A Minchella1, C Adjé-Touré2, G Zhang1

  • 1Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Insights

Simplifying pre-antiretroviral therapy (ART) screening in low-resource settings is feasible, as few patients exhibit conditions linked to ART toxicities. Targeted screening can balance safety and service efficiency for HIV care.

Area of Science:

  • Clinical Medicine
  • Public Health
  • Infectious Diseases

Background:

  • Health systems in low-resource settings face high demand for HIV services, necessitating resource optimization.
  • Simplifying services, such as pre-antiretroviral therapy (ART) laboratory screening, can reduce the burden on these systems.

Purpose of the Study:

  • To assess the frequency of conditions linked to ART toxicities in ART-naïve patients in Côte d'Ivoire.
  • To identify factors associated with these conditions and evaluate the potential for simplifying pre-ART screening.

Main Methods:

  • Retrospective analysis of 34,994 adult, ART-naïve patients' laboratory data from 1998-2017 in Abidjan, Côte d'Ivoire.
  • Screening included tests for renal dysfunction, hepatic abnormalities, and severe anaemia.
  • Analysis across four eras to identify trends and associated factors.

Main Results:

  • Only 8.4% of patients presented with renal dysfunction, hepatic abnormalities, or severe anaemia.
  • Prevalence of these conditions remained largely unchanged over time.
  • Factors associated with renal dysfunction and severe anaemia included age >50 years and CD4 count <100 cells/µl.

Conclusions:

  • The low prevalence of toxicity-related conditions supports simplifying pre-ART laboratory screening.
  • Targeted screening strategies can effectively balance the detection of adverse events with service simplification in HIV care.
Abstract